These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 33027420)

  • 21. Drug repurposing in the era of COVID-19: a call for leadership and government investment.
    Martin JH; Bowden NA
    Med J Aust; 2020 Jun; 212(10):450-452.e1. PubMed ID: 32372435
    [No Abstract]   [Full Text] [Related]  

  • 22. Tackling SARS-CoV-2: proposed targets and repurposed drugs.
    Joshi S; Joshi M; Degani MS
    Future Med Chem; 2020 Sep; 12(17):1579-1601. PubMed ID: 32564623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base.
    Taccone FS; Gorham J; Vincent JL
    Lancet Respir Med; 2020 Jun; 8(6):539-541. PubMed ID: 32304640
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug targets for COVID-19 therapeutics: Ongoing global efforts.
    Saxena A
    J Biosci; 2020; 45(1):. PubMed ID: 32661214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovering small-molecule therapeutics against SARS-CoV-2.
    Tiwari V; Beer JC; Sankaranarayanan NV; Swanson-Mungerson M; Desai UR
    Drug Discov Today; 2020 Aug; 25(8):1535-1544. PubMed ID: 32574699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic Therapy for COVID-19 Infection.
    Nusbaum N
    J Community Health; 2020 Jun; 45(3):435-436. PubMed ID: 32314081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.
    Abbasi J
    JAMA; 2020 Sep; 324(10):928. PubMed ID: 32897326
    [No Abstract]   [Full Text] [Related]  

  • 28. Repurposing existing drugs for COVID-19: an endocrinology perspective.
    Cadegiani FA
    BMC Endocr Disord; 2020 Sep; 20(1):149. PubMed ID: 32993622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of Artificial Intelligence in COVID-19 drug repurposing.
    Mohanty S; Harun Ai Rashid M; Mridul M; Mohanty C; Swayamsiddha S
    Diabetes Metab Syndr; 2020; 14(5):1027-1031. PubMed ID: 32634717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary delivery of nanostructured lipid carriers for effective repurposing of salinomycin as an antiviral agent.
    Pindiprolu SKSS; Kumar CSP; Kumar Golla VS; P L; K SC; S K EB; R K R
    Med Hypotheses; 2020 Oct; 143():109858. PubMed ID: 32516655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29.
    Alexander SPH; Armstrong JF; Davenport AP; Davies JA; Faccenda E; Harding SD; Levi-Schaffer F; Maguire JJ; Pawson AJ; Southan C; Spedding M
    Br J Pharmacol; 2020 Nov; 177(21):4942-4966. PubMed ID: 32358833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning.
    Ackerman EE; Shoemaker JE
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32993136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug Discovery Strategies for SARS-CoV-2.
    Shyr ZA; Gorshkov K; Chen CZ; Zheng W
    J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19.
    D'Acquarica I; Agranat I
    Drug Discov Today; 2020 Jul; 25(7):1121-1123. PubMed ID: 32371138
    [No Abstract]   [Full Text] [Related]  

  • 36. Repurposing minocycline for COVID-19 management: mechanisms, opportunities, and challenges.
    Singh H; Kakkar AK; Chauhan P
    Expert Rev Anti Infect Ther; 2020 Oct; 18(10):997-1003. PubMed ID: 32552044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paromomycin: A potential dual targeted drug effectively inhibits both spike (S1) and main protease of COVID-19.
    Tariq A; Mateen RM; Afzal MS; Saleem M
    Int J Infect Dis; 2020 Sep; 98():166-175. PubMed ID: 32579907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Existing Drugs Might Treat COVID-19.
    Abbasi J
    JAMA; 2020 Jun; 323(22):2239. PubMed ID: 32515802
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach.
    Iftikhar H; Ali HN; Farooq S; Naveed H; Shahzad-Ul-Hussan S
    Comput Biol Med; 2020 Jul; 122():103848. PubMed ID: 32658735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection.
    Martorana A; Gentile C; Lauria A
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32722574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.